Yuchuan Chen

Yuchuan Chen

Auto-generated profile, based on publicly available information

Yuchuan Chen

Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Institute of Medicinal Biotechnology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in Organic Letters
Verified
Journal Article
Closed access
SCShanshan Chang
Shanshan Chang
MCMeilian Cai
Meilian Cai
TXTongmei Xiao
Tongmei Xiao
YCYuchuan Chen
Yuchuan Chen
WZWuli Zhao
Wuli Zhao
MCMinghua Chen
Minghua Chen

21 November 2023 in Organic Letters
Verified
Journal Article
Closed access
YCYuchuan Chen
Yuchuan Chen
TXTongmei Xiao
Tongmei Xiao
SGShuyue Guo
Shuyue Guo
SCShanshan Chang
Shanshan Chang
XXXiaoming Xi
Xiaoming Xi
MCMinghua Chen
Minghua Chen

22 October 2022 in Journal of Asian Natural Products Research
Verified
Journal Article
Closed access
YCYu-Chuan Chen
Yu-Chuan Chen
LLLi-Juan Lei
Li-Juan Lei
TXTong-Mei Xiao
Tong-Mei Xiao
YXYan-Ni Xu
Yan-Ni Xu
JXJian-Guo Xing
Jian-Guo Xing
MCMinghua Chen
Minghua Chen
In this paper, we present the discovery of a novel salicylic acid derivative, moldavica acid A (1), and a new natural dibenzo[b,f]oxepin, moldavica acid B (2), together with four known phenylpropionic acids (3-6) and protocatechuic acid (7) that were isolated from Dracocephalum moldavica L. Their structures were elucidated by comprehensive spectroscopic methods, including infrared and nuclear magnetic resonance. Compound 1 is the first example of salicylic acid linking a carboxylated α-pyrone via an ethyl bridge. Beyond expanding the knowledge of the chemical diversity of D. moldavica, both compounds 1 and 2 were shown to upregulate the expression of Kruppel-like factor 2, which could serve as a prospective therapeutic target for the treatment of atherosclerosis. Graphical Abstract

6 May 2025 in Organic Letters
Verified
Journal Article
Closed access
TXTongmei Xiao
Tongmei Xiao
PZPeitao Zhang
Peitao Zhang
SGShuyue Guo
Shuyue Guo
BSBingjie Su
Bingjie Su
YCYuchuan Chen
Yuchuan Chen
MCMinghua Chen
Minghua Chen

14 December 2023
Verified
Conference Paper
Closed access
YXYeong-Yuh Xu
Yeong-Yuh Xu
Pao Sheng YenPao Sheng Yen
Pao Sheng Yen
YLYu-Hui Lin
Yu-Hui Lin
CLChung-Yu Lai
Chung-Yu Lai
YCYu-Chuan Chen
Yu-Chuan Chen
CLChuan-Kang Liu
Chuan-Kang Liu
This paper presents a convolutional neural network (CNN) model, underpinned by deep learning principles, tailored to predict endovascular intervention outcomes in patients with acute anterior circulation ischemic stroke. Recognizing the crucial role of predictive models in guiding patient prognosis and treatment selection, we partitioned our dataset into training and testing subsets. The proposed CNN model exhibited outstanding performance during its training phase, reaching a stellar accuracy rate of 100%. This performance was maintained during the testing phase, with an accuracy surpassing 94.12%. Such minimal deviation between training and testing accuracies underscores the robustness of our model and suggests a reduced likelihood of overfitting, enhancing its relevance for real-world clinical scenarios. These promising results signify a leap forward in harnessing the power of deep learning for medical prognostication, particularly in stroke intervention outcomes.